MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517094912 A) filed by Hadidianmoghaddam, Mostafa, Zanjan, Iran, on Oct. 2, for 'a combined and practical product based on targeted exercise, nutrition and medication.'
Inventor(s) include Hadidianmoghaddam, Mostafa.
The application for the patent was published on Nov. 14, under issue no. 46/2025.
According to the abstract released by the Intellectual Property India: "Diabetes, or blood sugar disease, is caused by the resistance of body cells to insulin. The prescribed medicine is prescribed despite the body's resistance to insulin, and this medicine prevents the rise of blood sugar to a large extent, but it does not eliminate insulin resistance, ...